BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 33966425)

  • 1. Analysis on the value of soluble intercellular adhesion molecule-1 (sICAM-1), alpha fetoprotein (AFP), and aspartate aminotransferase/platelet ratio index (APRI) in predicting the prognostic survival of patients with primary liver cancer after radiofrequency ablation.
    Guo C; Liang H; Yuan W; Qin Y
    Ann Palliat Med; 2021 Apr; 10(4):4760-4767. PubMed ID: 33966425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiality of α-fetoprotein (AFP) and soluble intercellular adhesion molecule-1 (sICAM-1) in prognosis prediction and immunotherapy response for patients with hepatocellular carcinoma.
    Cao W; Chen Y; Han W; Yuan J; Xie W; Liu K; Qiu Y; Wang X; Li X
    Bioengineered; 2021 Dec; 12(2):9435-9451. PubMed ID: 34696675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspartate aminotransferase-to-platelet ratio index for predicting late recurrence of hepatocellular carcinoma after radiofrequency ablation.
    Zhang X; Xin Y; Yang Y; Chen Y; Cao XJ; Wang Y; Fan Q; Zhou X; Li X
    Int J Hyperthermia; 2022; 39(1):437-445. PubMed ID: 35249443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the pre- to postoperative alpha-fetoprotein ratio in the prognostic evaluation of liver cancer after radiofrequency ablation.
    Luo B; Liu L; Bi J; Bao S; Zhang Y
    Int J Biol Markers; 2022 Sep; 37(3):306-313. PubMed ID: 35686334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative albumin-bilirubin grade combined with aspartate aminotransferase-to-platelet count ratio index predict outcomes of patients with hepatocellular carcinoma within Milan criteria after liver resection.
    Luo H; Li C; Chen L
    Biosci Trends; 2019 May; 13(2):176-181. PubMed ID: 31061272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel prognostic model based on AFP, tumor burden score and Albumin-Bilirubin grade for patients with hepatocellular carcinoma undergoing radiofrequency ablation.
    Huang J; Cui W; Xie X; Lin K; Jin D; Xie X; Zhuang B
    Int J Hyperthermia; 2023; 40(1):2256498. PubMed ID: 37733400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic α-fetoprotein, platelets and AST-to-platelet ratio index predict hepatocellular carcinoma in chronic hepatitis C patients with sustained virological response after antiviral therapy.
    Wu CK; Chang KC; Hung CH; Tseng PL; Lu SN; Chen CH; Wang JH; Lee CM; Tsai MC; Lin MT; Yen YH; Hu TH
    J Antimicrob Chemother; 2016 Jul; 71(7):1943-7. PubMed ID: 27073265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum alpha-fetoprotein response can predict prognosis in hepatocellular carcinoma patients undergoing radiofrequency ablation therapy.
    Kao WY; Chiou YY; Hung HH; Su CW; Chou YH; Wu JC; Huo TI; Huang YH; Wu WC; Lin HC; Lee SD
    Clin Radiol; 2012 May; 67(5):429-36. PubMed ID: 22153231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combination of serum oligosaccharide chain (G-test), alpha-fetoprotein, and aspartate aminotransferase to alanine aminotransferase ratio provides the optimal diagnostic value for early detection of hepatocellular carcinoma.
    Zhu W; Shi P; Liang A; Zhu Y; Fu J; Yuan S; Wu X
    BMC Cancer; 2022 Oct; 22(1):1061. PubMed ID: 36241994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The FIB-4 index is a significant prognostic factor in patients with non-B non-C hepatocellular carcinoma after curative surgery.
    Okamura Y; Ashida R; Yamamoto Y; Ito T; Sugiura T; Bekku E; Aramaki T; Uesaka K
    Langenbecks Arch Surg; 2016 Mar; 401(2):195-203. PubMed ID: 26943655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative prognostic value of alfa-fetoprotein density in patients with hepatocellular carcinoma undergoing radiofrequency ablation.
    Zhuang BW; Li W; Qiao B; Zhang N; Lin MX; Wang W; Kuang M; Lu MD; Xie XY; Xie XH
    Int J Hyperthermia; 2022; 39(1):1143-1151. PubMed ID: 36039777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial Alpha-Fetoprotein Response Predicts Prognosis in Hepatitis B-related Solitary HCC Patients After Radiofrequency Ablation.
    Yu SJ; Kwon JH; Kim W; Yoon JH; Lee JM; Lee JY; Cho EJ; Lee JH; Kim HY; Jung YJ; Kim YJ
    J Clin Gastroenterol; 2018 Mar; 52(3):e18-e26. PubMed ID: 28795996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting cancer-specific mortality in T1/2 hepatocellular carcinoma after radiofrequency ablation by competing risk nomogram: A population-based analysis.
    He Q; Xiong Y; Xia P; Yang X; Yu Y; Chen Z
    Clin Res Hepatol Gastroenterol; 2024 Feb; 48(2):102283. PubMed ID: 38219821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of radiofrequency ablation combined with transarterial chemoembolization and antiviral therapy on the prognosis and quality of life in primary chronic HBV-related liver cancer.
    Lu B; Zhu L; Wang X; Zhong L; Cheng Y; Fan J; Yu L
    J BUON; 2019; 24(5):1979-1984. PubMed ID: 31786864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ambulatory end-stage liver disease in Ghana; patient profile and utility of alpha fetoprotein and aspartate aminotransferase: platelet ratio index.
    Nartey YA; Awuku YA; Agyei-Nkansah A; Duah A; Bampoh SA; Ayawin J; Asibey SO; Björkström NK; Ye W; Afihene MY; Roberts LR; Plymoth A
    BMC Gastroenterol; 2020 Dec; 20(1):428. PubMed ID: 33357229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Performance of Serum Alpha-Fetoprotein for Detecting Early-Stage Hepatocellular Carcinoma Is Influenced by Antiviral Therapy and Serum Aspartate Aminotransferase: A Study in a Large Cohort of Hepatitis B Virus-Infected Patients.
    Qian X; Liu Y; Wu F; Zhang S; Gong J; Nan Y; Hu B; Chen J; Zhao J; Chen X; Pan W; Dang S; Lu F
    Viruses; 2022 Jul; 14(8):. PubMed ID: 36016291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early detection of hepatocellular carcinoma co-occurring with hepatitis C virus infection: A mathematical model.
    Zekri AR; Youssef AS; Bakr YM; Gabr RM; Ahmed OS; Elberry MH; Mayla AM; Abouelhoda M; Bahnassy AA
    World J Gastroenterol; 2016 Apr; 22(16):4168-82. PubMed ID: 27122667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of radiofrequency ablation combined with sorafenib for treating liver cancer complicated with portal hypertension and prognostic factors.
    Yang LM; Wang HJ; Li SL; Gan GH; Deng WW; Chang YS; Zhang LF
    World J Gastroenterol; 2024 Mar; 30(11):1533-1544. PubMed ID: 38617449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irregular vascular pattern by contrast-enhanced ultrasonography and high serum Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein level predict poor outcome after successful radiofrequency ablation in patients with early-stage hepatocellular carcinoma.
    Takada H; Tsuchiya K; Yasui Y; Nakakuki N; Tamaki N; Suzuki S; Nakanishi H; Itakura J; Takahashi Y; Kurosaki M; Asahina Y; Enomoto N; Izumi N
    Cancer Med; 2016 Nov; 5(11):3111-3120. PubMed ID: 27748052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiofrequency Ablation (RFA) Combined with Transcatheter Arterial Chemoembolization (TACE) for Patients with Medium-to-Large Hepatocellular Carcinoma: A Retrospective Analysis of Long-Term Outcome.
    Liu W; Xu H; Ying X; Zhang D; Lai L; Wang L; Tu J; Ji J
    Med Sci Monit; 2020 Jul; 26():e923263. PubMed ID: 32667906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.